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Abstract 
Objective: The goal of this study was to examine the prevalence of HIV among febrile patients seeking care in Mercy 
Hospital, Bo, Sierra Leone, in 2012–2013.
Results: A total of 1207 febrile persons were tested for HIV with Determine™ and SD Bioline rapid diagnostic tests 
kits that detect the presence of HIV antibodies and HIV p24 antigens. The overall prevalence of HIV among the tested 
patients was 8.9%, which is considerably higher than the < 2% prevalence of HIV reported previously in the general 
population. While these results are not sufficient to prove a causal relationship, the obtained data imply that HIV 
positive individuals may be more likely to suffer from febrile infectious diseases than individuals without HIV infection. 
Increasing the availability and use of HIV testing services will allow antiretroviral therapy to be accessed in a timely 
manner and improve health status among people living with HIV.
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Introduction
HIV/AIDS was first detected in Sierra Leone in 1987 
among commercial sex workers in the Bo and Kenema 
districts [1]. In 1993, the Sierra Leone National AIDS 
Control Programme reported an 8.4% national seroprev-
alence rate [2]. That study was conducted during a period 
of civil war in Sierra Leone (1991–2002), when rape and 
multiple perpetrator rape were commonplace [3]. Sur-
veys undertaken as the civil conflict was ending showed 
decreasing rates of HIV seroprevalence [4]. However, 
the inability of researchers to access participants from all 
demographics during this time of conflict led to concern 
that the sampled population did not accurately represent 
the national population as a whole.
In April 2002, the first national survey of HIV preva-
lence in Sierra Leone was conducted by the Sierra Leone 
Ministry of Health in collaboration with the U.S. Cent-
ers for Disease Control and Prevention (CDC). Based 
on specimens collected from 2412 persons aged 12 
to 49  years from 724 households, the weighted HIV 
seroprevalence rate was 0.9% [5]. Since that time, gov-
ernment-sponsored surveys reported national HIV prev-
alence in the range of 1–2% [6, 7], with the most recent 
survey reporting a 1.5% HIV positive rate for the general 
population [8]. However, while HIV rates of the overall 
population and of several key high-risk populations have 
been well documented [9], little is known about the bur-
den of HIV among individuals with febrile illnesses.
A higher rate of acute infectious diseases among indi-
viduals with HIV than those without HIV infection 
would suggest that HIV is not being adequately managed 
by antiretroviral medication. The primary goal of this 
analysis was to investigate the prevalence of HIV among 
febrile patients in Bo, Sierra Leone, using rapid HIV diag-
nostics. Fever remains a common symptom of primary 
HIV and the opportunistic infections that affect people 
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living with HIV [10]. A previous study within the study 
location reported a 25.9% (95% CI 24.8–27.1%) preva-
lence of self-reported febrile illnesses including HIV 
within a 6 month period [11].
Main text
Methods
The study was a part of a single-center, longitudinal, pro-
spective study conducted at the Mercy Hospital Research 
Laboratory in Bo, Sierra Leone, during the 1-year period 
from July 1, 2012, through June 30, 2013. The goal of 
the larger study was to determine the etiology of febrile 
disease within Mercy Hospital’s catchment area. Mercy 
Hospital offers inpatient treatment, but the vast major-
ity of its patients consult with clinicians at the hospi-
tal’s outpatient clinic. Local residents aged 6  years and 
older presenting to staff at Mercy Hospital with febrile 
symptoms or reporting a fever that began within the 
previous 7 days were eligible to participate. Febrile indi-
viduals were defined as persons with an oral temperature 
of 37.5  °C or greater or an axillary body temperature of 
38 °C or greater [12]. Those excluded from the study were 
local residents who were unwilling or unable to provide 
blood samples and children who for whom parental con-
sent (and, for older children, assent) were not obtained.
Whole blood samples collected from 1207 consented 
febrile individuals participating in the prospective cohort 
study were tested for HIV with the Determine™ HIV-1/2 
lateral flow immunoassay (LFIA) test (471 samples; Alere 
Medical Co., Matsudo-shi, Chiba, Japan) and/or the SD 
Bioline 4th Generation HIV Ag/Ab Combo LFIA (736 
samples; Standard Diagnostics Inc. Kyonggi-do, Korea). 
Both test kits meet the World Health Organization’s rec-
ommended standards for in  vitro diagnostic products 
[13]. The Determine™ test kit detects the presence of HIV 
antibodies with a 100% sensitivity and a 98.9% specificity 
[14]. The SD Bioline test kit detects both HIV antibodies 
and HIV p24 antigens, and it is reported to have a 99.8% 
sensitivity and a 100% specificity [13, 15]. HIV antibodies 
are typically indicative of chronic HIV infection, while 
the presence of p24 is a marker for the acute HIV infec-
tion that occurs in the weeks immediately following the 
initial exposure to the virus.
Blood samples were collected by trained and quali-
fied research staff. The assays were performed accord-
ing to the manufacturer instructions. A Deki Reader (Fio 
Corporation, Toronto, Canada) was used to capture the 
LFIA images and upload them to a cloud-based database 
hosted by Fio Corporation. The final determination of the 
outcome of the assays was based on the visual inspec-
tion of both the original tests by on-site researchers and 
uploaded images accessed remotely by team members 
located in the USA. Any positive test was repeated and 
also redone with the other brand of rapid test.
Epi Info software (CDC, Atlanta, USA) was used to 
estimate the sample size and to conduct statistical tests. 
Chi squared tests with a two-sided significant level of 
α  =  0.05 were used to evaluate statistical comparisons 
between various subpopulations by age group and sex.
Results
A total of 1207 febrile individuals (456 males and 751 
females) were tested for HIV using one or both of the 
rapid diagnostic devices. The overall prevalence of 
the presence of HIV antibodies was 8.3% (100/1207) 
(Table  1). Although the seroprevalence of HIV anti-
bodies ranged from 4.1 to 12.3% within different age 
groups, these differences were not statistically significant 
(p =  0.483). Male and female participants were equally 
likely to be HIV-seropositive (p  =  0.379). HIV antigen 
p24 consistent with early HIV infection was detected in 
8 of 736 tested individuals (1.1%; Table  2), with no sig-
nificant age- or sex-specific differences (p  >  0.335). As 
expected, all antigen-positive patients were negative for 
the presence of HIV antibodies.
Table 1 Prevalence of HIV antibodies within febrile individuals, 2012–2013 (SD bioline and determine HIV Ag/Ab LFIAs)
Age group Total Male Female
Number 
tested
Number posi-
tive
% HIV+ Number 
tested
Number posi-
tive
% HIV+ Number 
tested
Number posi-
tive
% HIV+
6–14 88 4 4.5 39 2 5.1 49 2 4.1
15–29 460 34 7.4 140 10 7.1 320 24 7.5
30–44 265 27 10.2 111 9 8.1 154 18 11.7
45–59 181 12 6.6 78 7 9.0 103 5 4.9
60+ 213 23 10.8 88 12 13.6 125 11 8.8
Total 1207 100 8.3 456 40 8.8 751 60 8.0
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Discussion
The overall prevalence of HIV infection among febrile 
individuals was 8.9% after including all participants 
who were positive for either antibody or antigen in the 
numerator of the calculation. This rate is almost six 
times greater than the 2012–2013 national HIV survey 
that found an HIV prevalence rate of 1.5% for the gen-
eral population and 1.4% for the population in Bo district 
[16]. Since the LFIAs used for our study generally require 
the presence of higher concentrations of HIV for a posi-
tive test than is required for the ELISA-based methods 
used in the national survey [17], the actual difference 
in the HIV rates in the current study of febrile patients 
and the national survey of the general population may be 
even bigger.
The large disparity between our results and those of 
the 2012–2013 national survey suggests a significant dif-
ference between the populations sampled for each of the 
studies. Variations in HIV prevalence based on age, soci-
oeconomic group, level of education, and other demo-
graphic characteristics may be partly responsible for the 
higher rate of HIV-positives in the current study [8]. 
However, the more likely cause of the large discrepancy 
in HIV rates is the intentional use of only febrile patients 
in this study. Several other studies in low-income coun-
tries have reported higher rates of HIV infection among 
febrile individuals than non-febrile individuals [18–20]. 
Fever is commonly associated with acute HIV infection 
(AHI), a febrile illness occurring shortly after HIV infec-
tion and characterized by the presence of HIV nucleic 
acids and/or p24 antigen, but not antibodies. However, in 
our study only small fraction of all subjects were positive 
for p24 (8/108) but not antibodies. These individuals may 
all have had acute HIV infections, but we did not confirm 
this with the  CD4+ counts that are typically used to eval-
uate disease progression to AIDS.
While a causal link cannot be made, the more plausible 
explanation of the large number of febrile patients sero-
positive for HIV antibodies suggests that HIV-infected 
individuals may have a higher incidence of non-AHI 
related febrile illnesses than people without HIV infec-
tion. These results are likely a consequence of a current 
gap in HIV testing and treatment in Sierra Leone, despite 
three decades of government efforts to prevent HIV 
infection and spread [21]. In Bo, where this study was 
carried out, about two-thirds of young adults have never 
sought testing for HIV, including 56% of women and 
75% of men [22]. The low testing rate means that many 
adults with HIV remain unaware of their HIV status and 
unaware of their need to seek HIV treatment. This data, 
combined with the fact that only 29% of individuals who 
are aware of their HIV-positive status in Sierra Leone 
receives antiretroviral therapy (ART) [23], points to a 
potentially large pool of people lacking proper manage-
ment of their HIV infection.
Perhaps the most striking observation from this 
study is the high rate of HIV infection in children ages 
6–14  years, most of whom are presumed to have con-
tracted HIV from their mothers [24]. Although we note 
that these results must be interpreted cautiously based 
on the limited number of children (n = 88) who partici-
pated in the study, the 4.1% rate observed among febrile 
children in this study is more than eight times greater 
than the 0.5% prevalence reported for this age group in 
the general population in 2015 [23]. This high rate in chil-
dren was unexpected, since about 80% of HIV-positive 
pregnant women in Sierra Leone receive ART [23]. ART 
reduces the rate of mother-to-child transmission to less 
than 2% if received during pregnancy and delivery [24]. 
This finding suggest that HIV infection may be associ-
ated with increased incidence of acute febrile infections 
in pediatric populations as well as adult populations.
Overall this study shows that almost one in eleven 
febrile patients reporting to Mercy Hospital is HIV sero-
positive. This suggests that HIV-related infections may 
account for a high proportion of use of the health system 
nationally. The contribution of HIV to the overall burden 
of disease may be underestimated after factoring in the 
Table 2 Prevalence of p24 antigens among febrile individuals positive for HIV, 2012–2013 (SD Bioline HIV Ag/Ab LFIA)
Age group Total Male Female
Number 
tested
Number posi-
tive
% HIV+ Number 
tested
Number posi-
tive
% HIV+ Number 
tested
Number posi-
tive
% HIV+
6–14 48 1 1.4 21 1 4.8 27 0 0.0
15–29 265 4 1.0 87 3 3.4 178 1 1.6
30–44 153 1 0.5 67 0 0.0 86 1 1.2
45–59 108 0 0.0 43 0 0.0 65 0 0.0
60+ 163 2 1.0 68 1 1.5 95 1 1.1
Total 736 8 0.8 286 5 1.7 451 3 0.4
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excess risk of comorbid infectious diseases among people 
with HIV infections. Additional funding for HIV man-
agement through ARTs may reduce the health system 
costs of treating acute and chronic secondary infections.
These findings also point toward the value of clini-
cal referrals for HIV voluntary counselling and testing 
(VCT). In Sierra Leone and other places where a large 
proportion of people with HIV do not know their status 
and are not receiving ART, it might be appropriate for 
health authorities to recommend that all febrile adults 
be referred for VCT. Since these individuals are already 
seeking care for their illnesses, they might be more likely 
to accept the referral and follow through on testing, 
receipt of the results, and follow-up care if the HIV test 
is positive. This kind of testing might also facilitate detec-
tion of acute HIV infection and enhance opportunities to 
control HIV spread.
Limitations
The major limitation of this study is that the participants 
consisted entirely of a convenience sample of individu-
als with acute febrile illnesses who were not randomly 
sampled from the population, and we did not include a 
comparison group to verify the < 2% HIV prevalence rate 
in the general (afebrile) population in the Mercy Hospi-
tal catchment area. We also did not measure CD4 counts 
or attempt to classify the stage of HIV infection among 
participants with positive HIV tests. Additionally, we did 
not have a large enough sample size to have the statistical 
power necessary for robust comparisons of HIV preva-
lence rates between various age-sex subpopulations.
Despite the limitations, the results may provide help-
ful information about the burden of acute febrile illnesses 
among people with HIV infection who live in Bo and, 
more generally, in Sierra Leone. Future studies that assess 
the prevalence of HIV among randomly-selected sub-
jects from general population are necessary to accurately 
assess the extent of the HIV epidemic in Sierra Leone, 
but it is likely that people with HIV infection account 
for a disproportionately high number of patients seeking 
diagnosis and treatment for acute undifferentiated febrile 
illnesses.
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